Skip to main content

Subcontracting Opportunities

 

 

 

 

Subcontracting allows small and disadvantaged businesses to substantially impact the federal procurement preference programs. Due to legislative mandates, federal prime contractors award billions of subcontracting dollars annually to small businesses — Small Business Subcontracting Plan requirements set forth in their contracts include requirements to track participation by veteran-owned, service-disabled veteran-owned, HUBZone, disadvantaged, and women-owned businesses.

 

USASpending.gov provides information on organizations who have a prime contractor relationship with the NCI. The current Frederick National Laboratory for Cancer Research (FNLCR) prime contractor has significant subcontracting opportunities — see FNLCR Acquisitions for further information.

NCI also maintains a list of its active Indefinite Delivery/Indefinite Quantity (ID/IQ) Prime Contractors. NCI encourages businesses to network and establish teaming arrangements to support these contracting vehicles, which are used to place a variety of orders for supplies and services through processes that do not involve public posting after the base ID/IQ contract(s) have been awarded.

Indefinite Delivery/Indefinite Quantity (ID/IQ) Prime Contractors
Contract Name(s) Contract Specialist Title & Brief Description From Article B.1. Base Period of Performance (Start-End Dates)
Universite Laval Reyes Rodriguez Services to determine serum concentrations of samples collected by the Hormonal and
Reproductive Epidemiology Branch (HREB).
9/1/2015 - 8/31/2020
Datawaves Miguel Diaz Technology Transfer Center TIMS database Maintenance and Upgrades 9/20/2015 - 9/19/2020
Repeat Diagnostics, Inc. Miguel Diaz Laboratory Testing Services of Telomere Length Assays for the Inherited Bone Marrow Failure Study 9/20/2015 - 9/19/2020
ASTERAND US ACQUISITION CORP Mary Muir Tissue source site for CPTAC Program 9/22/2015 - 9/21/2020
Artificial Intelligence in Medicine Reyes Rodriguez Surveillance Epidemiology and End Results (SEER) Electronic Data Capture Software Support and Installations 9/26/2015 - 9/25/2020
BIOMATRIX Mary Muir Tissue source site for CPTAC Program 9/29/2015 - 9/28/2020
GLOBAL BIOCLINICAL Mary Muir Tissue source site for CPTAC Program 9/29/2015 - 9/28/2020
Evotec (US), Inc. Mike Collins Title: Chemical Biology Consortium Screening Libraries Center/ Brief Description: Store and maintain the CBCSLC approximately 135,000 small molecule screening collections 9/30/2015 - 9/29/2020
22nd Century Technologies Inc. Christine Biser SharePoint Maintenance & Support Services (NCCIH & NCI) 10/17/2015 - 10/16/2020
IIMO (POLAND) Mary Muir Tissue source site for CPTAC Program 12/30/2015 - 12/29/2020
INTERNATIONAL GENOMICS CONSORTIUM Mary Muir Tissue source site for CPTAC Program 1/15/2016 - 1/14/2021
ANALYTICAL BIOLOGICAL SERVICES Mary Muir Tissue source site for CPTAC Program 1/19/2016 - 1/18/2021
BEAUMONT HEALTH Mary Muir Tissue source site for CPTAC Program 2/24/2016 - 2/23/2021
BOSTON MEDICAL CENTER Mary Muir Tissue source site for CPTAC Program 2/24/2016 - 2/23/2021
BIOPARTNERS Mary Muir Tissue source site for CPTAC Program 2/24/2016 - 2/23/2021
Westat, Inc Linda Park The Contractor shall provide support for centralized follow-up of participants from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening and the National Lung Screening (NLST) Trials. The PLCO was designed to determine if screening for prostate, lung, colorectal and ovarian cancer can reduce mortality from these cancers. The National Lung Screening Trial (NLST) was a randomized controlled trial designed to determine whether screening for lung cancer with low-dose helical computed tomography (CT) reduces mortality from lung cancer in high-risk individuals relative to screening with chest radiography. 3/1/2016 - 2/28/2021
Fisher BioServices Inc Lexi Hudak This IDIQ supports the NCI's Chemotherapeutic Agents Repository (NCI-CAR).  This contract 1) supports compound acquisition activities related to the DTP anticancer pre-clinical drug evaluation program which seeks to identify new small molecule therapeutic agents and 2) distributes chemicals to intramural and extramural investigators for research purposes. Primary tasks are receipt, registration, storage, analysis, arraying and distribution of small molecules and purified natural products.  This contract is also responsible for providing an informational interface with NCI and external investigators that are submitting or requesting research compounds; for updating of the chemical database which includes chemical, inventory, receiving and shipping information; systematic file and record keeping of both current and archival information related to Repository activities; and reacquisition of samples for continued chemical and biological studies.     3/1/2016 - 2/28/2021
CEDARS-SINAI MEDICAL CENTER Mary Muir Tissue source site for CPTAC Program 3/2/2016 - 3/1/2021
U. OF CALIFORNIA SAN DIEGO Mary Muir Tissue source site for CPTAC Program 3/23/2016 - 3/22/2021
North American Association of Central Cancer Registries (NAACCR) Kate Muir The objective of this contract is provide support to the North American Association of Central Cancer Registries
(NMCCR) in order to make the National Cancer lnstitute's (NCI) cancer surveillance program more responsive to the needs of the division, institute, and nation, and more integrated with other partners within the national cancer surveillance enterprise.This contract focuses on three specific areas: (1) Strengthening the national capacity for collecting, analyzing, and using comparable cancer registry data for cancer surveillance and research. (2) Developing
and improving methods for assessing the quality and comparability of cancer registry data. This includes, but is not limited to timeliness, completeness, and accuracy. (3) Improving the efficiency and quality of registry operationsthrough promoting established standards, disseminating technical information, and facilitating collaboration among Federal, state, provincial and local registry professionals.
7/1/2014 - 6/30/2021
IITRI Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 7/1/2014 - 6/30/2021
SRI International Lexi Hudak The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program. 7/1/2014 - 6/30/2021
Southern Research Lexi Hudak The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program. 7/1/2014 - 6/30/2021
University of Pittsburgh Lexi Hudak The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program. 7/1/2014 - 6/30/2021
IITRI Lexi Hudak The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program. 7/1/2014 - 6/30/2021
Mayo Clinic Lexi Hudak The pupose of this acquisition is to continue implementation of bioanalytical methods and to conduct pharmacokinetic evaluations in aniamls with compounds of interest to the NCI Therapeutics (NeXT) Program. 7/1/2014 - 6/30/2021
Battelle Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 7/1/2016 - 6/30/2021
SRI Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 7/1/2016 - 6/30/2021
Southern Research Institute Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 7/1/2016 - 6/30/2021
UIC Randall Tiqui Preclinical Toxicology Study of Drugs Developed for Cancer and Other Diseases 7/1/2016 - 6/30/2021
Ganges, Mary Bruce Biological Research Consultant Jolomi Omatete Tissue Culture technician support p to 9000 hours with a minimum of 1400 hours 8/20/2016 - 8/19/2021
Vignet Michael Apata This contract shall provide technical services to the Applied Research Program (ARP), in the Division of Cancer Control and Population Sciences (DCCPS) within the National Cancer Institute (NCI). ARP has needs for developmental and technical services in a broad range of content areas, including cancer-associated health behaviors, health services, and outcomes from cancer treatment. Within each of these content areas, common needs are for study management, questionnaire development, and database development and management 9/12/2014 - 9/11/2021
CDM Group Michael Apata Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 9/12/2014 - 9/11/2021
Gunnison Michael Apata Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 9/12/2014 - 9/11/2021
Vsolvit Michael Apata Technical Services for the NCI Applied Research Program - This contract provides a broad range of developmental and technical services related to cancer-associated health behaviors, health services and outcomes for cancer treatment. The services include study management, questionnaire development, and database development and management. 9/12/2014 - 9/11/2021
Vanderbilt University Medical Center Miguel Diaz Laboratory Testing Services for Circulating Inflammation Markers and Prospective Risk of Gastric Cancer Related to the H Pylor 9/14/2016 - 9/13/2021
D's Ventures LLC, dba LOGMET Megan Kisamore Procurement of Gardasil-9 Vaccines in support of NCI/CCR 9/18/2018 - 9/18/2021
Invitae Corporation David Romley Lab Testing/Dicer I Genetic Testing 9/19/2016 - 9/21/2021
American Type Culture Collection Rukshani Levy The Contractor shall provide Molecular Epidemiology Assay Support (MEAS) to the Division of Cancer Epidemiology and Genectics. 5/6/2017 - 3/5/2022
Metabolon, Inc. Rukshani Levy The Contractor shall provide metabolomic profiling services for DCEG studies using liquid chromatography and gas chromatography mass spectrometry (LC-MS). 6/14/2017 - 6/13/2022
MRIGlobal Junli Collins Analysis of bulk drug samples and their
pharmaceutical formulations
8/1/2017 - 7/31/2022
RTI International Junli Collins Analysis of bulk drug samples and their
pharmaceutical formulations
8/1/2017 - 7/31/2022
SRI International Junli Collins Analysis of bulk drug samples and their
pharmaceutical formulations
8/1/2017 - 7/31/2022
Nationwide Children's Hospital Wilkison, Paula Biospcimen Core Resource (BCR) 8/25/2017 - 8/24/2022
Bizzell Group Park, Linda Tobacco Control Research Scientific and Technical Services Support 9/1/2017 - 8/31/2022
Bayer Healthcare LLC Jolomi Omatete BPX30 Disposable Endorectal Coils for 3.OT MRI Scanner 9/10/2017 - 9/17/2022
Genepria Consulting Inc. Jolomi Omatete Statistical and Programming Appplications 9/12/2017 - 9/11/2022
Alchem Christine Biser Synthesis of Non-GMP Small Molecules 9/18/2017 - 9/17/2022
Connecticut Department of Public Health Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area.
ASE Direct Inc. Adam Hernandez Erlotinib Tablets 1/24/2020 - 1/23/2023
Fundacion INCIENSA Tom Conroy Evaluation of Single Dose Protection Afforded by the Prophylactic HPV vaccines 8/1/2017 - 7/31/2023
Medidata Solutions Pooja Rathore Rave Hosting, Maintenance,  and Professional Services, and License, Hosting, Maintenance, and Professional Services for Rave integrated anicillary services. 9/1/2018 - 8/31/2023
Synergy Randall Tiqui NCI Center for Global Health, Logistics, Data Analysis and Technical Support 9/17/2018 - 9/16/2023
IIT Research Institute Mike Collins PREVENT Preclinical Drug Development Program (Efficacy Pool) 1/25/2019 - 1/24/2024
SRI International Mike Collins PREVENT Efficacy studies 1/25/2019 - 1/24/2024
Illinois Univ, TRL Christy Hunter PREVENT Efficacy studies 1/25/2019 - 1/24/2024
University of Texas, MD Anderson Christy Hunter PREVENT Efficacy studies 1/25/2019 - 1/24/2024
The Research Institute of Fox Chase Cancer Center Christy Hunter PREVENT Efficacy studies 1/25/2019 - 1/24/2024
IIT Research Institute Mike Collins PREVENT Preclinical Drug Development Program (Toxicology Pool) 1/25/2019 - 1/24/2024
SRI International Mike Collins PREVENT Preclinical Drug Development Program (Toxicology Pool) 1/25/2019 - 1/24/2024
Illinois Univ, TRL Christy Hunter PREVENT Preclinical Drug Development Program (Toxicology Pool) 1/25/2019 - 1/24/2024
Southern Research Institute Christy Hunter PREVENT Preclinical Drug Development Program (Toxicology Pool) 1/25/2019 - 1/24/2024
University of Alabama at Birmingham Mike Collins PREVENT Efficacy studies 1/25/2019 - 1/24/2024
University of Oklahoma Health Sciences Center Mike Collins PREVENT Efficacy studies 1/25/2019 - 1/24/2024
Leidos Biomedical Research Scott Keasey The Contractor shall, in accordance with the provisions of this contract, support the missions and programs assigned under contract with the National Cancer Institute and manage and operate the National Cancer Institute’s Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR). The purpose of the FFRDC is to provide a unique biomedical research and development resource for the development of new technologies and the translation of basic science discoveries into novel agents for the prevention, diagnosis, and treatment of cancer, Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS), and other diseases in support of the NCI, NIAID, other NIH ICs and other government agencies. The FFRDC serves as a flexible, quick-response mechanism to accomplish the most urgent national/global health initiatives for the NCI/NIH and other government agencies. 6/26/2019 - 6/25/2024
Carl Zeiss Miguel Diaz Maintenance Service Support for Zeiss Confocal and Epifluorescence Microscopes at the NCI CCR Microscopy Core Facilities. 8/1/2019 - 7/31/2024
Advanced Bioscience Laboratories Megan Osele PREVENT Preclinical Drug Development Program: CGMP Production of Vaccines and Biologicals for Cancer Prevention 8/14/2019 - 1/24/2024
International AIDS Vaccine Initiative Megan Osele PREVENT Preclinical Drug Development Program: CGMP Production of Vaccines and Biologicals for Cancer Prevention 8/14/2019 - 1/24/2024
Kindred Biosciences Megan Osele PREVENT Preclinical Drug Development Program: CGMP Production of Vaccines and Biologicals for Cancer Prevention 8/14/2019 - 1/24/2024
The University of North Carolina at Chapel Hill Randall Tiqui NCI's Genomics Characterization Center 8/31/2019 - 8/30/2024
University of California Randall Tiqui NCI's Genomics Characterization Center 8/31/2019 - 8/30/2024
Washington University in St. Louis Randall Tiqui NCI's Genomics Characterization Center 8/31/2019 - 8/30/2024
The Broad Institute, Inc Lexi Hudak NCI's Genomic Characterization Center IDIQ  Contract 8/31/2019 - 8/30/2024
Genewiz, LLC Lexi Hudak NCI's Genomic Characterization Center IDIQ  Contract 8/31/2019 - 8/30/2024
New York Genome Center Lexi Hudak NCI's Genomic Characterization Center IDIQ  Contract 8/31/2019 - 8/30/2024
University of North Carolina at Chapel Hills Lexi Hudak NCI's Genomic Characterization Center IDIQ  Contract 8/31/2019 - 8/30/2024
University of Southern California Lexi Hudak NCI's Genomic Characterization Center IDIQ  Contract 8/31/2019 - 8/30/2024
Washington University Lexi Hudak NCI's Genomic Characterization Center IDIQ  Contract 8/31/2019 - 8/30/2024
Roche Diagnostics Corporation Jolomi Omatete BenchMark Ultra Reagents and Consumables 9/22/2019 - 9/21/2024
PBG Consulting LLC Junli Collins NCI CSSI Technical, Programmatic and Other Support Services 7/15/2020 - 7/14/2025
5/1/2018 - 4/30/2028
Emory University Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Fred Hutchinson Cancer Research Center Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Health Research, Inc. Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Idaho Hospital Association Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Louisiana State University Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Massachusetts Department of Public Health Angela Moore Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Public Health Institute Kate Muir Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Cancer Prevention Institute of California (CPIC) Kate Muir Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
University of Hawaii Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
University of Iowa Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
University of Kentucky (Research Foundation) Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
University of New Mexico Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
University of Southern California Kate Muir Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
University of Utah Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Wisconsin Department of Health Services Chris Mills Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
UCSF Kate Muir Surveillance, Epidemiology and End Results (SEER) Program - collects and reports on population based cancer incidence and survival data on all patients in the legally described catchment area. 5/1/2018 - 4/30/2028
Kaiser Foundation Hospitals Nikki Arena The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort 6/4/2018  - 6/3/2028
Henry Ford Health System Erica Rosario The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort 6/4/2018 - 6/3/2028
Sanford Research Erica Rosario The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort 6/4/2018 - 6/3/2028
The University of Chicago Nikki Arena The Contractor shall recruit and retain participants, collect and process biospecimens, administer online questionnaires, and link to electronic medical records in support DCEG's NextGeneration Cohort 6/4/2018 - 6/3/2028
       
       

 

  • Updated: